A novel effect of nicotine on mood and sleep in major depression

No abstract is available for this paper.

• Publication year

  1998

• Venue

  NeuroReport

• Publication date

  1998-01-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00001756-199801050-00012PMID 9592048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Major depression following smoking cessation.

  1997cited by this paper
• Transdermal nicotine on sleep and PGO spikes.

  1996cited by this paper
• Effects of transderman nicotine on mood and sleep in nonsmoking major depresssed patients

  1995cited by this paper
• Antidepressant and Antimanic Drugs

  1995cited by this paper
• Dose‐Dependent Effects of Transdermal Nicotine on Early Morning Awakening and Rapid Eye Movement Sleep Time in Nonsmoking Normal Volunteers

  1994cited by this paper
• How reliable are operationalized diagnosis? The test-retest reliability of Structured Clinical Interview for DSM-III-R (SCID)

  1992cited by this paper
• Long-term enhancement of REM sleep following cholinergic stimulation.

  1991cited by this paper
• Smoking, smoking cessation, and major depression.

  1990cited by this paper
• Microinjections of nicotine in the medial pontine reticular formation elicits REM sleep.

  1990cited by this paper
• Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.

  1989cited by this paper
• Cholinergic mechanisms in depression.

  1986cited by this paper
• Development and use of pharmacological probes of the CNS in man: evidence of cholinergic abnormality in primary affective illness.

  1980cited by this paper
• Cholinergic mechanisms and cataplexy in dogs.

  1979cited by this paper
• A review of REM sleep deprivation.

  1975cited by this paper
• A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects.

  1969cited by this paper
• Effects of some stimulant and depressant drugs on sleep cycles of cats

  1966cited by this paper
• Nicotine: Effect on the Sleep Cycle of the Cat

  1965cited by this paper

• Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression.

  2024cites this paper
• Historia de la investigación en trastornos del sueño y de su primera clínica en México

  2024cites this paper
• Brief Sensations Seeking Scale (BSSS): Validity Evidence in Mexican Adolescents

  2022cites this paper
• Emotional symptoms and sensation seeking: Implications for tobacco interventions for youth and young adults

  2021cites this paper
• Antidepressant effect of methanol extract of smokeless tobacco and identification of its bioactive components

  2021cites this paper
• Nicotine treatment buffers negative behavioral consequences induced by exposure to physical and emotional stress in adolescent male mice

  2020cites this paper
• Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

  2019cites this paper
• Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.

  2018cites this paper
• Early life adversity and health‐risk behaviors: proposed psychological and neural mechanisms

  2018cites this paper
• Depressed Mood Improvement through Nicotine Dosing ( Depressed MIND Study ) Version 1 . 3 , 04 / 13 / 2017 VICTR : VR 20324 Clinicaltrials . gov Identifier : NCT 02816138 PI :

  2018cites this paper
• Effect of nicotine on serotonin (5-HT) levels in brain of depressed rats

  2017cites this paper
• Transdermal Nicotine Patch Effects on EEG Power Spectra and Heart Rate Variability During Sleep of Healthy Male Adults

  2017cites this paper
• The Effect of Smoking on Mental Health.

  2017cites this paper
• Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway

  2017cites this paper
• Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.

  2017cites this paper
• Sleep and mental disorders: A meta-analysis of polysomnographic research.

  2016cites this paper
• Diphenyl diselenide supplementation in infected mice by Toxoplasma gondii: Protective effect on behavior, neuromodulation and oxidative stress caused by disease.

  2016cites this paper
• Effects of smoking and smoking cessation on mental disorders

  2016cites this paper
• Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington’s disease model in rats

  2016cites this paper
• Nicotine and Stimulatory Effects on 5-HT DRN Neurons

  2016cites this paper
• ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.

  2015cites this paper
• Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests

  2015cites this paper
• acetylcholine receptor raphe serotonergic neurons through alpha7 nicotinic Nicotine increases GABAergic input on rat dorsal

  2014cites this paper
• Nicotine effects on human affective functions: a systematic review of the literature on a controversial issue.

  2014cites this paper
• Nicotine increases GABAergic input on rat dorsal raphe serotonergic neurons through alpha7 nicotinic acetylcholine receptor.

  2014cites this paper
• Flattening plasma corticosterone levels increases the prevalence of serotonergic dorsal raphe neurons inhibitory responses to nicotine in adrenalectomised rats.

  2013cites this paper
• Nicotinic modulation of serotonergic activity in the dorsal raphe nucleus

  2013cites this paper
• Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.

  2013cites this paper
• Der Zusammenhang zwischen Sucht und Schlaf: „legale“ Drogen

  2013cites this paper
• NEONATAL TREATMENT WITH CLOMIPRAMINE AND DEPRESSION: A REVIEW OF BEHAVIORAL AND PHYSIOLOGICAL FINDINGS*

  2011cites this paper
• Nikotin

  2010cites this paper
• Orchiectomy modifies the antidepressant-like response of nicotine in the forced swimming test.

  2010cites this paper
• Ansiedad y depresión en fumadores mexicanos y su relación con el grado de adicción

  2010cites this paper
• [Anxiety and depression in Mexican smokers, and their relationship with the severity of addiction].

  2010cites this paper
• Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.

  2010cites this paper
• Interactions of nicotine and drugs used in the treatment of mental illnesses with respect to cognitive functions

  2010cites this paper
• Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats

  2010cites this paper
• [Nicotine as an antidepressant and regulator of sleep in subjects with depression].

  2009cites this paper
• Association between smoking and minimal-mild depressive symptomatology in heavy smokers

  2009cites this paper
• Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.

  2009cites this paper
• Effects of Smoking on Hormones, Brain, and Behavior

  2009cites this paper
• Acción de la nicotina como antidepresivo y regulador del sueño en sujetos deprimidos

  2009cites this paper
• A guide to what works for depression

  2009cites this paper
• Cue-evoked positive affect, depression vulnerability and smoking years.

  2009cites this paper
• Effects of nicotine in experimental animals and humans: an update on addictive properties.

  2009cites this paper
• Effects of nicotine on sleep during consumption, withdrawal and replacement therapy.

  2009cites this paper
• Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia

  2009cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• Risperidone Treatment of Borderline Personality Disorder Assessed by a Borderline Personality Disorder–Specific Outcome Measure

  2008cites this paper
• TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity

  2008cites this paper
• Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.

  2008cites this paper
• The Endocannabinoid System in the Physiology and Pathology of the Basal Ganglia

  2008cites this paper
• DESIGN, SYNTHESIS, AND PHARMACOLOGICAL EVALUATION OF A SERIES OF NOVEL, GUANIDINE AND AMIDINE-CONTAINING NEONICOTINOID-LIKE ANALOGS OF NICOTINE: SUBTYPE-SELECTIVE INTERACTIONS AT NEURONAL NICOTINIC-ACETYLCHOLINE RECEPTOR.

  2008cites this paper
• Galantamine as an adjunctive treatment in major depression.

  2008cites this paper
• Tabaquismo y depresión

  2008cites this paper
• Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.

  2008cites this paper
• Mitochondrial NAD+‐linked State 3 respiration and complex‐I activity are compromised in the cerebral cortex of 3‐nitropropionic acid‐induced rat model of Huntington’s disease

  2007cites this paper
• Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in mexico city

  2007cites this paper
• Long-term changes in sleep and depressive symptoms of smokers in abstinence.

  2007cites this paper
• Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls

  2007cites this paper
• Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia

  2007cites this paper
• Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial

  2006cites this paper
• NICOTINIC RECEPTOR MODULATION OF DOPAMINE TRANSPORTERS

  2006cites this paper
• Effects of nicotine replacement therapies on sleep.

  2006cites this paper
• The effect of transdermal nicotine patches on sleep and dreams.

  2006influential citation
• Effect of nicotine on negative affect among more impulsive smokers.

  2006cites this paper
• Nicotine as a typical drug of abuse in experimental animals and humans

  2006cites this paper
• Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes.

  2006cites this paper
• Tabagisme et troubles du sommeil

  2006cites this paper
• Şizofreni ve Sigara İçimi: Biyolojik Bağlanti Nerede?

  2006cites this paper
• [Smoking and schizophrenia: where is the biological connection?].

  2006cites this paper
• Nicotine, Sleep, and Depression

  2006cites this paper
• Cannabinoid control of motor function at the basal ganglia.

  2005cites this paper
• Chapter 115 – Medication and Substance Abuse

  2005cites this paper
• Developmental Heterogeneity in Adolescent Depressive Symptoms: Associations With Smoking Behavior

  2005cites this paper
• Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients

  2004cites this paper
• ALFREDO GURREA ESCAJEDO*; Mª CRISTINA PINET OGUÉ**

  2004cites this paper
• Nicotinic acetylcholine receptor system and neuropsychiatric disorders.

  2004cites this paper
• Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine].

  2004cites this paper
• A Two-Year Study on the Effects of Nicotine and its Withdrawal on Mood and Sleep

  2004cites this paper
• Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients.

  2004cites this paper
• Postnatal development of glutamatergic receptormediated excitatory postsynaptic currents and their modulations by ach and dopamine in nucleus accumbens

  2004cites this paper
• Tabaco y patología afectiva

  2004cites this paper
• Succinate increases neuronal post-synaptic excitatory potentials in vitro and induces convulsive behavior through N-methyl-d-aspartate-mediated mechanisms.

  2004cites this paper
• The Effect of Nicotine Patch Therapy on Depression in Nonsmokers

  2004cites this paper
• [Nicotine acetylcholine receptors and neuropsychiatric disorders].

  2004cites this paper
• Nicotine and nicotinic receptor involvement in neuropsychiatric disorders.

  2003cites this paper
• Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients.

  2003cites this paper
• Nicotine dependence and psychiatric disorders.

  2003cites this paper
• Plasma levels of corticosterone and testosterone after sexual activity in male rats treated neonatally with clomipramine

  2003cites this paper
• Reviews of Physiology, Biochemistry and Pharmacology

  2003cites this paper
• Mood disorders in patients with COPD: overview of current research and future needs

  2003cites this paper
• Reboxetine: attenuation of intravenous nicotine self-administration in rats.

  2002cites this paper